Your External Chemistry Team From First Molecule to Seed Milestone
At Oxeltis, we understand the unique reality of drug discovery startups: limited resources, tight timelines, and investors watching every decision. We act as your embedded scientific team, providing expert-level chemistry, computation, and biology without the overhead of building it yourself, so you can focus your capital on the science that matters most.
01 — YOUR CHALLENGES
The challenges drug discovery startups face
- No in-house chemistry capacity
Most drug discovery startups are founded on a biological or computational insight, not a chemistry team. Without synthesis expertise on day one, turning hits into testable molecules stalls before it begins.
- Every dollar and every week counts
Hiring senior chemists is expensive and slow. A failed synthesis or a poorly designed synthetic route at this stage doesn't just cost money, it costs runway, and potentially the program.
- Milestone pressure from investors
Seed and Series A investors expect defined chemistry milestones (validated hits, confirmed SAR, or a lead compound) on a timeline that leaves no room for CRO miscommunication or coordination delays.
02 — HOW WE HELP
How Oxeltis supports drug discovery startups
03 — YOUR DEDICATED TEAM
Senior scientists. Startup mindset.
Startups don't get a second chance at a first milestone. That's why we assign a dedicated Oxeltis project leader to every startup engagement. A senior scientist who serves as your single point of contact, coordinates all chemistry, computational, and biological workstreams across the consortium, and communicates proactively before problems arise. No account managers. No coordination overhead. Just scientists who care about your program as much as you do.
We are also acutely aware of IP sensitivity at the startup stage. Our engagements are governed by robust confidentiality agreements, and we never share client data, compounds, or program details across projects. Your science is yours, always.
04 — RELEVANT SERVICES FOR Startups
Services most relevant to Startups
- Custom Synthesis & Route Scouting
Route scouting before synthesis begins, protecting your budget by identifying the most efficient pathway upfront, then delivering compounds with full analytical documentation at any scale your program requires.
- Computer-Aided Drug Design (CADD)
Capital-efficient computational prioritization: reduce the number of compounds synthesized by 30–50% and make every synthesis decision count. Critical when resources are limited and milestones are non-negotiable.
- Medicinal Chemistry & Hit-to-Lead
A dedicated PhD medicinal chemistry team acting as your external chemistry department from first analog design through to an optimized, investor-ready lead compound.
- Biological Screening
Integrated bioactivity data (via Partex.AI Labs), timed to your milestones and formatted for investor and SAB presentations, produced in direct coordination with your chemistry program.
Ready to hit your next chemistry milestone, on time and on budget?
Tell us where your program stands and what you need to reach your next milestone. We'll come back with a clear proposal within 48 hours.